+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 110 Pages
  • January 2022
  • Region: Global
  • IMARC Group
  • ID: 5530389
The global cardiovascular implants market reached a value of US$ 23.0 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 33.6 Billion by 2027, exhibiting a CAGR of 6.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, they are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor



Cardiovascular implants are used for patients suffering from cardiovascular conditions such as heart failure, myocardial infarction, and peripheral arterial and coronary artery diseases. Depending on their intended use, there are two broad categories of cardiovascular implants. The first type of implants remain inside the patients’ body throughout their lives to support or perform heart functions. On the other hand, temporary implants are utilized during surgeries or other medical procedures for taking over or managing heart functions. The growing prevalence of heart diseases, owing to changing dietary patterns, sedentary lifestyles and rising geriatric population, has resulted in high demand for cardiovascular implants across the globe

Global Cardiovascular Implants Market Drivers:

Rising prevalence of cardiovascular disorders represents a key factor driving the demand of cardiovascular implants. Catalyzed by unhealthy diets and sedentary lifestyles, the prevalence of various cardiovascular disorders has increased across both developed and developing countries. Improving efficacy and safety of cardiovascular implants represents another major factor spurring the market growth. For instance, recent advancements in technology have opened opportunities for developing smart stent devices which can improve the diagnosis as well treatment of previously unmanageable conditions such as atherosclerosis and central line access failure. Apart from this, various government and non-profit organizations are also taking initiatives to improve the affordability of these devices. Other factors driving this market include ageing population, development in medical infrastructure, growing awareness levels and rising popularity of minimally invasive surgeries

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global cardiovascular implants market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product type, material, procedure type and indication

Breakup by Product Type:

  • Coronary Stent
  • ICD
  • Heart Valve
  • Implanted Cardiac Pacemaker
  • CRT Device
  • Peripheral Stent

Based on the product type, the market has been segmented into coronary stent, ICD, heart valve, implanted cardiac pacemaker, CRT device and peripheral stent

Breakup by Material:

  • Metals and Alloys
  • Polymers
  • Biological Materials

Based on the material, the market has been segmented into metals and alloys, polymers and biological materials

Breakup by Procedure Type:

  • Angioplasty
  • Open Heart Surgery

Based on the procedure type, the market has been segmented into angioplasty and open-heart surgery

Breakup by Indication:

  • Arrhythmias
  • Myocardial Ischemia
  • Acute Myocardial Infarction
  • Congestive Heart Failure
  • Others

Based on the indication, the market has been segmented into arrhythmias, myocardial ischemia, acute myocardial infarction, congestive heart failure and others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America

Competitive Landscape:

The competitive landscape of the market has also been examined with some of the key players being Biotronik, Abbott Laboratories, AMG International, B-Braun, Johnson & Johnson, W.L. Gore & Associates, Medtronic, Boston Scientific, Sorin, Edwards Lifesciences, Fortimedix, Neovasc Inc., On-X Life Technologies, Proxy Biomedical, Reva Medical and Shree Pacetronix Ltd

Key Questions Answered in This Report:

  • How has the global cardiovascular implants market performed so far and how will it perform in the coming years?
  • What is the breakup of the global cardiovascular implants market on the basis of region?
  • What has been the impact of COVID-19 on the global cardiovascular implants market?
  • What is the breakup of the global cardiovascular implants market on the basis of product type?
  • What is the breakup of the global cardiovascular implants market on the basis of material?
  • What is the breakup of the global cardiovascular implants market on the basis of procedure type?
  • What is the breakup of the global cardiovascular implants market on the basis of indication?
  • What are the various stages in the value chain of the global cardiovascular implants market?
  • What are the key driving factors and challenges in the global cardiovascular implants market?
  • What is the structure of the global cardiovascular implants market and who are the key players?
  • What is the degree of competition in the global cardiovascular implants market?
Frequently Asked Questions about the Global Cardiovascular Implants Market

What is the estimated value of the Global Cardiovascular Implants Market?

The Global Cardiovascular Implants Market was estimated to be valued at $23 Billion in 2021.

What is the growth rate of the Global Cardiovascular Implants Market?

The growth rate of the Global Cardiovascular Implants Market is 6.5%, with an estimated value of $33.6 Billion by 2027.

What is the forecasted size of the Global Cardiovascular Implants Market?

The Global Cardiovascular Implants Market is estimated to be worth $33.6 Billion by 2027.

Who are the key companies in the Global Cardiovascular Implants Market?

Key companies in the Global Cardiovascular Implants Market include Biotronik, Abbott Laboratories, AMG International, B, Braun, Johnson & Johnson, W.L. Gore & Associates, Medtronic and Sorin.

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cardiovascular Implants Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product Type
5.5 Market Breakup by Material
5.6 Market Breakup by Procedure Type
5.7 Market Breakup by Indication
5.8 Market Breakup by Region
5.9 Market Forecast
6 Market Breakup by Product Type
6.1 Coronary Stent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 ICD
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Heart Valve
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Implanted Cardiac Pacemaker
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 CRT Device
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Peripheral Stent
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Material
7.1 Metals and Alloys
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Polymers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biological Materials
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Procedure Type
8.1 Angioplasty
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Open Heart Surgery
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Indication
9.1 Arrhythmias
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Myocardial Ischemia
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Acute Myocardial Infarction
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Congestive Heart Failure
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast
11 Global Cardiovascular Implants Industry: SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Global Cardiovascular Implants Industry: Value Chain Analysis
13 Global Cardiovascular Implants Industry: Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Global Cardiovascular Implants Industry: Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Biotronik
15.3.2 Abbott Laboratories
15.3.3 AMG International
15.3.4 B-Braun
15.3.5 Johnson & Johnson
15.3.6 W.L. Gore & Associates
15.3.7 Medtronic
15.3.8 Boston Scientific
15.3.9 Sorin
15.3.10 Edwards Lifesciences
15.3.11 Fortimedix
15.3.12 Neovasc Inc.
15.3.13 On-X Life Technologies
15.3.14 Proxy Biomedical
15.3.15 Reva Medical
15.3.16 Shree Pacetronix Ltd
List of Figures
Figure 1: Global: Cardiovascular Implants Market: Major Drivers and Challenges
Figure 2: Global: Cardiovascular Implants Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cardiovascular Implants Market: Breakup by Product Type (in %), 2021
Figure 4: Global: Cardiovascular Implants Market: Breakup by Material (in %), 2021
Figure 5: Global: Cardiovascular Implants Market: Breakup by Procedure Type (in %), 2021
Figure 6: Global: Cardiovascular Implants Market: Breakup by Indication (in %), 2021
Figure 7: Global: Cardiovascular Implants Market: Breakup by Region (in %), 2021
Figure 8: Global: Cardiovascular Implants Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Cardiovascular Implants Industry: SWOT Analysis
Figure 10: Global: Cardiovascular Implants Industry: Value Chain Analysis
Figure 11: Global: Cardiovascular Implants Industry: Porter’s Five Forces Analysis
Figure 12: Global: Cardiovascular Implants (Coronary Stent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Cardiovascular Implants (Coronary Stent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Cardiovascular Implants (ICD) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Cardiovascular Implants (ICD) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Cardiovascular Implants (Heart Valve) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Cardiovascular Implants (Heart Valve) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Cardiovascular Implants (Implanted Cardiac Pacemaker) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Cardiovascular Implants (Implanted Cardiac Pacemaker) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Cardiovascular Implants (CRT Device) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Cardiovascular Implants (CRT Device) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Cardiovascular Implants (Peripheral Stent) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Cardiovascular Implants (Peripheral Stent) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Cardiovascular Implants (Metals and Alloys) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Cardiovascular Implants (Metals and Alloys) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Cardiovascular Implants (Polymers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Cardiovascular Implants (Polymers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Cardiovascular Implants (Biological Materials) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Cardiovascular Implants (Biological Materials) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Cardiovascular Implants (Angioplasty) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Cardiovascular Implants (Angioplasty) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Cardiovascular Implants (Open Heart Surgery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Cardiovascular Implants (Open Heart Surgery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Cardiovascular Implants (Arrhythmias) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Cardiovascular Implants (Arrhythmias) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Cardiovascular Implants (Myocardial Ischemia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Cardiovascular Implants (Myocardial Ischemia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Cardiovascular Implants (Acute Myocardial Infarction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Cardiovascular Implants (Acute Myocardial Infarction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Cardiovascular Implants (Congestive Heart Failure) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Cardiovascular Implants (Congestive Heart Failure) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Cardiovascular Implants (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Cardiovascular Implants (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: North America: Cardiovascular Implants Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: North America: Cardiovascular Implants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Europe: Cardiovascular Implants Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Europe: Cardiovascular Implants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Asia Pacific: Cardiovascular Implants Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Asia Pacific: Cardiovascular Implants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Middle East and Africa: Cardiovascular Implants Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Middle East and Africa: Cardiovascular Implants Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Latin America: Cardiovascular Implants Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Latin America: Cardiovascular Implants Market Forecast: Sales Value (in Million US$), 2022-2027
List of Tables
Table 1: Global: Cardiovascular Implants Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cardiovascular Implants Market Forecast: Breakup by Product Type (in Million US$), 2022-2027
Table 3: Global: Cardiovascular Implants Market Forecast: Breakup by Material (in Million US$), 2022-2027
Table 4: Global: Cardiovascular Implants Market Forecast: Breakup by Procedure Type (in Million US$), 2022-2027
Table 5: Global: Cardiovascular Implants Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 6: Global: Cardiovascular Implants Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Cardiovascular Implants Market Structure
Table 8: Global: Cardiovascular Implants Market: Key Players

Companies Mentioned

  • Biotronik
  • Abbott Laboratories
  • AMG International
  • B-Braun
  • Johnson & Johnson
  • W.L. Gore & Associates
  • Medtronic
  • Boston Scientific
  • Sorin
  • Edwards Lifesciences
  • Fortimedix
  • Neovasc Inc.
  • On-X Life Technologies
  • Proxy Biomedical
  • Reva Medical
  • Shree Pacetronix Ltd.

Methodology

Loading
LOADING...